NCT06236841View on ClinicalTrials.gov

A Phase I Study of XH-S004 in Healthy Volunteers

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

January 26, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Healthy Adults
Interventions
DRUG

XH-S004 tablet

XH-S004 tablets will be administered orally as per assigned treatment regimen on schedualed days.

DRUG

XH-S004 placebo tablet

XH-S004 placebo tablet (matched) will be administered orally as per assigned treatment regimen on schedualed days.

Trial Locations (1)

Unknown

Beijing LuHe Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

S-INFINITY Pharmaceuticals Co., Ltd

INDUSTRY